Skip to main content
logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.07
+0.57 (4.22%)
Jul 21, 2026, 10:07 AM EDT - Market open

Summit Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,206-1,080-221.32-614.93-78.78-88.6
Depreciation & Amortization
0.170.150.090.21.262.46
Stock-Based Compensation
794.12732.4250.9814.1111.9512.8
Other Adjustments
-8.16-7.3312.66524.3814.120.82
Change in Receivables
---0.360.98-1.14
Changes in Accounts Payable
21.7515.32.022.26-4.13-1.71
Changes in Accrued Expenses
26.1815.8418.44-2.616.398.23
Changes in Unearned Revenue
-----7.28-0.81
Changes in Other Operating Activities
-13.130.27-4.97-0.5313.91-4.63
Operating Cash Flow
-384.05-322.93-142.11-76.76-41.58-72.59
Capital Expenditures
-0.48-0.66-0.14-0.13-0.62-0.31
Sale of Property, Plant & Equipment
---0.23--
Purchases of Investments
--484.99-680.03-321.02--
Proceeds from Sale of Investments
328.1311.34489.84208.17--
Payments for Business Acquisitions
---15.01-475.02--
Investing Cash Flow
-334.66-174.31-205.34-587.77-0.62-0.31
Long-Term Debt Issued
----545110
Long-Term Debt Repaid
---100-24.69-25-110
Net Long-Term Debt Issued (Repaid)
---100-24.695200
Issuance of Common Stock
9.09617.53481.23111.82100.478.09
Net Common Stock Issued (Repurchased)
9.09617.53481.23111.82100.478.09
Other Financing Activities
----0.62-0.16-0.17
Financing Cash Flow
613.65617.53381.2386.51620.2477.92
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.050.1-0.020.84-1.220.35
Net Cash Flow
-105.01120.433.76-577.18576.825.37
Free Cash Flow
-384.53-323.59-142.25-76.89-42.21-72.89
Free Cash Flow Per Share
-0.51-0.43-0.20-0.12-0.22-0.55
Levered Free Cash Flow
1,085-1,049-305.89-640.42450.75-85.38
Unlevered Free Cash Flow
1,2571,125211.41-432.99-62.56-82.97
SEC Filings: 10-K · 10-Q